Related Experiment Video
Updated: May 12, 2026

11:17
Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer
Published on: February 27, 2026
Pyothorax-associated lymphoma: complete remission achieved by chemotherapy alone
Tomoki Nakagawa1, Takayuki Nakano, Ryota Masuda
1Department of General Thoracic Surgery, Tokai University Tokyo Hospital, Tokyo, Japan, k167999@is.icc.u-tokai.ac.jp.
General Thoracic and Cardiovascular Surgery
|March 30, 2013
Summary
A rare case of pyothorax-associated lymphoma (PAL) in an 81-year-old female, stemming from tuberculosis treatment, achieved complete remission with R-CHOP therapy and showed no recurrence over four years.
Area of Science:
- Oncology
- Thoracic Surgery
- Infectious Disease Epidemiology
Background:
- Artificial pneumothorax was historically used to treat pulmonary tuberculosis.
- Chronic pyothorax can arise as a complication of artificial pneumothorax.
- Malignant lymphoma is a rare but serious complication of chronic inflammation.
Observation:
- An 81-year-old female presented with back pain, a history of artificial pneumothorax for tuberculosis, and chronic pyothorax.
- Imaging revealed a large tumor associated with the left sixth and seventh ribs.
- Biopsy confirmed pyothorax-associated lymphoma.
Findings:
- The patient received four cycles of R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone) chemotherapy.
- Complete remission of the lymphoma was achieved following treatment.
- No evidence of recurrence was observed during a four-year follow-up period.
Implications:
- This case highlights the potential long-term oncogenic risk of chronic inflammatory conditions like pyothorax.
- Pyothorax-associated lymphoma is a treatable malignancy, even in elderly patients.
- Effective chemotherapy regimens can lead to durable remissions, improving patient outcomes.
Related Concept Videos
Pneumothorax-II
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...